These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2165363)

  • 21. Cardiovascular effects and modulation of noradrenergic neurotransmission following central and peripheral administration of neuropeptide Y.
    Westfall TC; Martin J; Chen XL; Ciarleglio A; Carpentier S; Henderson K; Knuepfer M; Beinfeld M; Naes L
    Synapse; 1988; 2(3):299-307. PubMed ID: 2850631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous NPY (27-36)-D decreases cardiac output in conscious Sprague-Dawley rats.
    Roscoe AK; Nyce J; Wooles WR
    Peptides; 1996; 17(3):539-43. PubMed ID: 8735985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y infusion improves hemodynamics and survival in rat endotoxic shock.
    Hauser GJ; Myers AK; Dayao EK; Zukowska-Grojec Z
    Am J Physiol; 1993 Oct; 265(4 Pt 2):H1416-23. PubMed ID: 7902007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide Y (NPY) induced inhibition of preganglionic nerve stimulation evoked release of adrenalin and noradrenaline in the pithed rat.
    Dahlöf P; Persson K; Lundberg JM; Dahlöf C
    Acta Physiol Scand; 1988 Jan; 132(1):51-7. PubMed ID: 2851918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y prevents the blood pressure fall induced by endotoxin in conscious rats with adrenal medullectomy.
    Evéquoz D; Waeber B; Aubert JF; Flückiger JP; Nussberger J; Brunner HR
    Circ Res; 1988 Jan; 62(1):25-30. PubMed ID: 3335055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Central catecholamine-neuropeptide Y interactions at the pre- and postsynaptic level in cardiovascular centers.
    Fuxe K; Härfstrand A; Agnati LF; Kalia M; Fredholm B; Svensson T; Gustafsson JA; Lang R; Ganten D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S1-13. PubMed ID: 2455156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of neuropeptide Y (NPY) in cardiovascular responses to stress.
    Zukowska-Grojec Z; Vaz AC
    Synapse; 1988; 2(3):293-8. PubMed ID: 3212674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of gender on the central actions of neuropeptide Y and norepinephrine on vasopressin and blood pressure in the rat.
    Sato K; Crofton JT; Wang YX; Share L
    Brain Res; 1995 Aug; 689(1):71-8. PubMed ID: 8528707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
    Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
    Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of neuropeptide Y on the blood pressure response to various vasoconstrictor agents.
    Aubert JF; Waeber B; Rossier B; Geering K; Nussberger J; Brunner HR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1088-92. PubMed ID: 2843627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects and cardiopulmonary plasma gradients following intravenous infusion of neuropeptide Y in humans: negative dromotropic effect on atrioventricular node conduction.
    Ullman B; Pernow J; Lundberg JM; Aström H; Bergfeldt L
    Clin Sci (Lond); 2002 Dec; 103(6):535-42. PubMed ID: 12444905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
    Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
    Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic pressor action of neuropeptide Y and norepinephrine in conscious rats.
    Itoi K; Mouri T; Takahashi K; Sasaki S; Imai Y; Yoshinaga K
    J Hypertens Suppl; 1986 Dec; 4(6):S247-50. PubMed ID: 3475412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain neuropeptide Y mechanisms. Basic aspects and involvement in cardiovascular and neuroendocrine regulation.
    Härfstrand A
    Acta Physiol Scand Suppl; 1987; 565():1-83. PubMed ID: 2829507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
    Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
    Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-alpha-biotinylated-neuropeptide Y analogs: syntheses, cardiovascular properties, and application to cardiac NPY receptor visualization.
    Balasubramaniam A; Sheriff S; Ferguson DG; Stein M; Rigel DF
    Peptides; 1990; 11(6):1151-6. PubMed ID: 1965029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE; Lundberg JN; Weitzberg E
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Galanin N-terminal fragment (1-15) interacts with neuropeptide Y in central cardiovascular control: Involvement of the NPY Y2 receptor subtype.
    Díaz-Cabiale Z; Parrado C; Narváez M; Millón C; Puigcerver A; Fuxe K; Narváez JA
    Regul Pept; 2010 Aug; 163(1-3):130-6. PubMed ID: 20451563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.